Can you recognize a patient at risk for a hypercoagulable state?
Author:
- 1 December 2008
- journal article
- review article
- Published by Wolters Kluwer Health in JAAPA
- Vol. 21 (12) , 20-26
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- β‐Thalassaemia and sickle cell anaemia as paradigms of hypercoagulabilityBritish Journal of Haematology, 2007
- Anti‐platelet and anti‐thrombotic approaches in patients undergoing percutaneous coronary interventionCatheterization and Cardiovascular Interventions, 2007
- Heparin, Low Molecular Weight Heparin, and Derivatives in Thrombosis, Angiogenesis, and Inflammation: Emerging LinksSeminars in Thrombosis and Hemostasis, 2007
- How I treat patients with polycythemia veraBlood, 2007
- Antiplatelet Therapy for Atherothrombotic Disease: An Update for the Primary Care PhysicianMayo Clinic Proceedings, 2007
- Thrombocytosis: When is an incidental finding serious?Cleveland Clinic Journal of Medicine, 2006
- Platelet biology – an overviewTransfusion Alternatives in Transfusion Medicine, 2006
- Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activityClinical Endocrinology, 2006
- Platelets in AtherothrombosisMayo Clinic Proceedings, 2006
- Coagulation and Fibrinolysis in DiabetesSeminars in Vascular Medicine, 2002